Enhanced vasoconstriction and reduced vasorelaxation induced by testosterone and nandrolone in hypercholesterolemic rabbits

Pharmacological Research

Volumn 50, Issue 3, 2004, Pages 253-259

  Ammar, E M ^a   Said, Shehta A ^a   Hassan, Mohammed S ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Androgenic anabolic steroids (AAS); Aortic rings; Endothelin 1; Nandrolone; Testosterone

Indexed keywords

ADENOSINE; ADRENALIN; ENDOTHELIN 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NANDROLONE; NITROPRUSSIDE SODIUM; SEROTONIN; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; ISOLATION PROCEDURE; LIPID BLOOD LEVEL; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR RING; VASOCONSTRICTION; VASODILATATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERCHOLESTEROLEMIA; MALE; NANDROLONE; RABBITS; SUBSTANCE-RELATED DISORDERS; TESTOSTERONE; VASOCONSTRICTION; VASODILATION;

EID: 3042545595     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2004.03.010     Document Type: Article

References (37)

1. Bagatell C.J., Bremner W.J. Androgens in men - uses and abuses. N. Engl. J. Med. 334:1996;707-714
2. Griffin JE, Wilson JD. Disorders of the testes and the male reproductive tract. In: Wilson JD, Foster DW, editors. Williams textbook of endocrinology. 8th ed. Philadelphia: W.B. Saunders; 1992. p. 799-852.
3. National Institute on Drug Abuse (NIDA). Research report. Anabolic steroid abuse; 2000.
4. Huie M.J. An acute myocardial infarction occurring in an anabolic steroid user. Med. Sci. Sports Exerc. 26:1994;408-413
5. Fischer M., Appleby M., Rittoo D., Cotter L. Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br. J. Clin. Pract. 50:1996;222-223
6. Fineschi V., Baroldi G., Monciotti F., Paglicci R.L., Turillazzi E. Anabolic steroid abuse and cardiac sudden death. Arch. Pathol. Lab. Med. 125:2001;253-255
7. Kennedy M.C., Lawrence C. Anabolic steroid abuse and cardiac death. Med. J. Aust. 158:1993;346-348
8. Dickerman R.D., Schaller F., Prather I., McConathy W.J. Sudden cardiac death in a 20-year-old body builder using anabolic steroids. Cardiology. 86:1995;172-173
9. Meuis C., Spyridopoulos I., Kühlkamp V., Seipel L. Manifestation of severe coronary heart disease after anabolic drug abuse. Clin. Cardiol. 19:1996;153-155
10. Frankle M.A., Eichberg R., Zachariah S.B. Anabolic androgenic steroids and a stroke in an athlete: a case report. Arch. Phys. Med. Rehabil. 69:1988;632-633
11. DeStefano V., Leone G., Teofili L., et al. Transient ischemic attack in a patient with congenital protein C deficiency during treatment with stanozolol. Am. J. Hematol. 29:1988;120-121
12. Varriale P., Mirzai-tehrane M., sedighi A. Acute myocardial infarction associated with anabolic steroids in a young HIV-infected patient. Pharmacotherapy. 19:1999;881-884
13. Kolodgie F.D., Katocs A.S., Largis E.E., et al. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol: methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arteriosceler. Thromb. Vasc. Biol. 16:1996;1454-1464
14. Hutchison S.J., Sudhir K., Chou T.M., et al. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J. Am. Coll. Cardiol. 29:1997;800-807
15. Ferrer M., Encabo A., Marin J., Balfagen G. Chronic treatment with the anabolic steroid, nandrolone, inhibits vasodilator responses in rabbit aorta. Eur. J. Pharmacol. 252:1994;233-241
16. Alexandersen P., Haarbo J., Byrjalsen I., Lawaetz H., Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ. Res. 84:1999;813-819
17. Yue P., Chatterjee K., Beale C., Poole-Wilson P.A., Callins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 91:1995;1154-1160
18. Glazer G. Atherogenic effects of anabolic steroids on serum lipids levels. Arch. Intern. Med. 151:1991;1925-1933
19. Fogelberg M., Bjorkhem I., Diczfalusy U., Henricksson P. Stanozolol and experimental atherosclerosis: atherosclerotic development and blood lipid during anabolic steroid therapy of New Zealand white rabbits. Scand. J. Clin. Lab. Invest. 50:1990;693-696
20. 2-cholesterol and increase hepatic triglyceride lipase activity. Med. Sci. Sports Exerc. 17:1985;462-465
21. Applebaum-Bowden D., Haffner S.M., Hazzard W.R. Dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high-density lipoprotein cholesterol. Metabolism. 36:1987;949-952
22. Baldo-enzi G., Giada F., Zuliani G., et al. Lipid and apoprotein modifications in bodybuilders during and after self-administration of anabolic steroids. Metabolism. 39:1990;203-208
23. Tikkanen M.J., Nikkila E.A. Regulation of hepatic lipase and serum lipoproteins by sex steroid. Am. Heart. J. 113:1987;562-567
24. Schänzer W. Metabolism of anabolic androgenic steroids. Clin. Chem. 42:1996;1001-1020
25. Sullivan M.L., Martinez C.M., Gennis P., Gallagher E.J. The cardiac toxicity of anabolic steroids. Prog. Cardiovasc. Dis. 41:1998;1-15
26. Greenberg S., George W.R., Kadowitz P.J., Wilson W.R. Androgen-induced enhancement of vascular reactivity. Can. J. Physiol. Pharmacol. 52:1974;12-22
27. Baker P.J., Ramey E.R., Ramwell P.W. Androgen-mediated sex differences of cardiovascular responses in rat. Am. J. Physiol. 235:1978;H242-H246
28. Teoh H., Quan A., Leung S.W.S., Man P.Y.K. Differential effects of 17β-estradiol and testosterone on the contractile responses of porcine coronary arteries. Br. J. Pharmacol. 129:2000;1301-1308
29. Ferrer M., Encabo A., Marin J., Balfagon G. Treatment with the anabolic steroid, nandrolone, reduces the vasoconstrictor responses in rabbit arteries. Eur. J. Pharmacol. 258:1994;103-110
30. Galle J., Bassenge E., Busse T. Oxidized low-density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ. Res. 66:1990;1287-1293
31. Giardina J.B., Tanner D.J., Khalil R.A. Oxidized-LDL enhances coronary vasoconstriction by increasing the activity of proteinkinase C isoforms alpha and epsilon. Hypertension. 37:2001;561-568
32. Verbeuren T.J., Jordaens F.H., Zonnekeyn L.L., Van Hove C.E., Coene M.C., Herman A.G. Effect of hypercholesterolemia on vascular reactivity in the rabbit I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ. Res. 58:1986;552-564
33. Nako J., Chang W.C., Murota S.I., Orimo H. Testosterone inhibits prostacycline production by rat aortic smooth muscle cells in culture. Atherosclerosis. 39:1981;203-209
34. Bracamonte M.P., Miller V.M. Vascular effects of estrogens: arterial protection versus venous thrombotic risk. Trends Endocrinol. Metab. 12:2001;204-209
35. Green DJ, Cable NT, Rankin JM, et al. Anabolic androgenic steroids and vascular responses. Lancet 1993;342-863.
36. Costarella CE, Stallone JN, Rutecki GW, Witteier FC. Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther 1996;277:34.
37. Deenadaylau V.P., White lone J.N., Gao A.J.X., Garcia A.J. Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channels. Am. J. Physiol. 281:2001;H1720-H1727